Ipratropium bromide nasal spray for treatment of rhinorrhea in the laryngectomized patient: A pilot study

American Journal of Rhinology

Volumn 15, Issue 3, 2001, Pages 203-206

  Magardino, Thomas M ^a,d   Suskind Liu, Dana ^b   Kroger, Hans ^c   Mirza, Natasha ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d Ravdin Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LARYNGECTOMY; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINORRHEA; TREATMENT OUTCOME;

EID: 0034969226     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065801779954201     Document Type: Article

References (3)

1. Meltzer EO, Orgel HA, Bronsky EA, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol 90:242-249, 1992.
2. Borts MR, and Druce HM. The use of intranasal anticholinergic agents in the treatment of nonallergic perennial rhinitis. J Allergy Clin Immunol 90:1065-1070, 1992.
3. Meltzer EO. Intranasal anticholinergic therapy of rhinorrhea. J Allergy Clin Immunol 90:1055-1064, 1992.